Thermo Fisher Scientific Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay

Tuesday, 15 December, 2020 | Supplied by: Thermo Fisher Scientific


Thermo Fisher Scientific has announced a direct-from-saliva PCR test for COVID-19 to enable widespread, high-frequency surveillance testing. The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and is designed to simplify lab workflows using instruments that are widely available to deliver data quickly.

By performing the test directly from raw saliva and eliminating the need for equipment, materials, time and labour associated with nucleic acid extraction, the assay helps labs meet the CDC turnaround time recommendations. It provides global communities with access to surveillance testing that is easy to implement, so they can manage the spread of COVID-19 and return to a sense of normalcy.

The assay is suitable for institutions of higher learning with existing laboratories. Universities that do not have labs on campus can also benefit by partnering with third-party testing providers. These reference labs can leverage the assay’s workflow to support increases in testing volume.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons

Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...

Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei

The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...

EpigenTek MethylFlash Hydroxymethylated DNA Quantification Kit (Fluorometric)

The kit is a complete set of optimised buffers and reagents to fluorometrically quantify global...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd